Skip to main content


24 Nov, 2016 Objective 3: GHP Trial Updates (October - November 2016)
Gynuity Health Projects, in collaboration with colleagues at Government Medical College, Nagpur and Daga Women’s Hospital are conducting a pragmatic, open-label, randomised control trial of three oral antihypertensive regimens for women with severe hypertension in pregnancy. Women presenting with severe hypertension will be randomised to one of... Read More
7 Oct, 2016 PRE-EMPT 2015-2016 Annual Report
We are excited to announce that the PRE-EMPT 2015-2016 Annual Report is now available online! This 109-page report highlights the progress and activities that we have accomplished from November 2015 to September 2016, and our intended deliverables for the upcoming 2017 year. A printed version of the annual report will be made available at the ISSHP World Congress... Read More
30 Sep, 2016 Saving Lives at Birth (SL@B) 6th Annual DevelopmentXChange in Washington, D.C.
From 26-28 July 2016, Saving Lives at Birth (SL@B) held its 6th annual DevelopmentXChange at the Ronald Reagan Building, Washington D.C. The event brings the brightest minds across the globe together to identify and scale up transformative prevention and treatment approaches for pregnant women and newborns. The DevelopmentXChange is an opportunity for innovators to showcase... Read More
30 Sep, 2016 Objective 2: Predictive Model for Postpartrum Haemorrhage and Sepsis Project (August - September 2016)
We are excited to announce our new Predictive Model for Postpartrum Haemorrhage and Sepsis project, which has been made possible through the funding from Saving Lives at Birth (Grand Challenges Canada). We have initiated a predictive modelling project focussed on hypotension. The principal investigators of the project are Peter von Dadelszen and Mark Ansermino, from St.... Read More
30 Sep, 2016 Objective 3: STRIDER Update (August - September 2016)
The Randomised Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (STRIDER) randomised control trials have been designed to determine whether maternal treatment with oral sildenafil citrate improves perinatal outcomes in pregnancies complicated by severe early-onset intrauterine growth restriction, without increasing risks to... Read More
30 Sep, 2016 CLIP's Second Feasibility Supplement Published in BMC Reproductive Health
PRE-EMPT is excited to announce that we have published nine articles in BMC Reproductive Health in a special issue titled ‘Building community-level resilience for the care of women with pre-eclampsia’. This is our second supplement in BMC Reproductive Health that highlights findings from the feasibility research conducted for the Community-Level... Read More
29 Sep, 2016 CLIP Health Geographer Tatenda Makanga Successfully Defends his PhD
Congratulations to Prestige Tatenda Makanga for successfully defending his PhD thesis entitled "The place of geographic information and analysis in global health: A case of maternal health in regions of southern Mozambique" from the Department of Geography at Simon Fraser University (SFU) on 26 August 2016. Tatenda is the health geographer for the Community-Level Interventions... Read More
29 Sep, 2016 Ending Eclampsia's First Webinar on Undernutrition and Hypertension
Ending Eclampsia seeks to expand access to proven, underutilised interventions and commodities for the prevention, early detection, and treatment of pre-eclampsia and eclampsia and to strengthen global partnerships. On 15 September 2016, the organization held its first webinar entitled "How Undernutrition and Hypertension Impact Pre-eclampsia and Eclampsia and Pre-... Read More
29 Sep, 2016 Global Pregnancy Collaboration (CoLab): Updates (August- September 2016)
Photo: Attendees of the CoLab meeting at Oriel College, University of Oxford, UK, 29 – 31 August 2016 Our most exciting news centres around our recent annual membership meeting that took place at Oriel College, University of Oxford, UK, 29 – 31 August 2016. We had the attendance of 42 participants, including 28 CoLab Steering Committee members, 8 invited... Read More
29 Sep, 2016 The Preeclampsia Foundation is hosting its first Preeclampsia and HELLP Syndrome Patient Advocates Summit
The Preeclampsia Foundation is hosting its first-ever Preeclampsia and HELLP Syndrome Patient Advocates Summit. The Summit is taking place 13 - 15 October 2016, at the Buena Vista Palace Resort in Orlando, Florida. Registration is full for the Summit, and will be attended by women who have experienced hypertension in pregnancy, such as pre-eclampsia, eclampsia, or HELLP... Read More